Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss

ABSTRACT

Background and Objectives@#We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results. @*Subjects and Methods@#We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated. @*Results@#Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B) 10.309, 95% confidence interval (CI) 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B) 1.042, 95% CI 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B) 25.641, 95% CI 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results. @*Conclusions@#A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.